Lv31
344 积分 2025-03-23 加入
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
2分钟前
已完结
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer
27分钟前
已完结
Nuclear NAD + promotes innate immune memory by inhibiting KDM5A-dependent histone demethylation
5天前
已完结
Coordinated nicotinamide metabolism by NAMPT and NNMT: Integrating metabolic, epigenetic and immune crosstalk
1个月前
已完结
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
3个月前
已完结
HKDC1-Mediated Polyamine Rewiring Drives Lenvatinib Resistance and Immune Escape in Hepatocellular Carcinoma
4个月前
已完结
Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma
5个月前
已完结
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial
6个月前
已完结
A Large-Scale Method to Measure the Stoichiometries of Protein Poly-ADP-Ribosylation
8个月前
已完结
PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy
8个月前
已完结
皖公网安备34019202002308
